Evidence of proatherogenic inflammation in polycystic ovary syndrome

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works

Obesity is associated with macrophage accumulation in adipose tissue

Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · see citing works

Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report

(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,452 · see citing works

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050 · see citing works

Inflammation in atherosclerosis

Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315 · see citing works

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)

The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138 · see citing works

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · see citing works

Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases

Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,622 · see citing works

Inflammation in Atherosclerosis

Libby, P. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,748 · see citing works

Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis

Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,761 · see citing works

Untitled work

(1998) · PubMed · Cited by 2,737 · see citing works

Interleukin-6 and the acute phase response

Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734 · see citing works

A rapid micrqpreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells

Andrews, N. C., & Faller, D. V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.9.2499 · Cited by 2,337 · see citing works

Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes

Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232 · see citing works

Men at risk: occupation and male infertility.

Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,219 · see citing works

Weight gain as a risk factor for clinical diabetes mellitus in women

Colditz, G. A., Willett, W. C., Rotnitzky, A., & Manson, J. E. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-7-199504010-00001 · Cited by 2,064 · see citing works

Comparison of the Release of Adipokines by Adipose Tissue, Adipose Tissue Matrix, and Adipocytes from Visceral and Subcutaneous Abdominal Adipose Tissues of Obese Humans

Fain, J. N., Madan, A. K., Hiler, M. L., Cheema, P. S., & Bahouth, S. W. (2004) · Endocrinology · doi:10.1210/en.2003-1336 · Cited by 1,571 · see citing works

Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study1

Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,568 · see citing works

Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.

Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,181 · see citing works

Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis

Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/er.18.6.774 · Cited by 1,167 · see citing works

Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study

Knochenhauer, E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3078 · Cited by 1,134 · see citing works

Correlation of Hyperandrogenism with Hyperinsulinism in Polycystic Ovarian Disease*

Burghen, G. A., Givens, J. R., & Kitabchi, A. E. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-1-113 · Cited by 922 · see citing works

C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by Macrophages

Zwaka, T. P., Hombach, V., & Torzewski, J. (2001) · Circulation · doi:10.1161/01.cir.103.9.1194 · Cited by 845 · see citing works

Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque Rupture

Newby, A. C. (2005) · Physiological Reviews · doi:10.1152/physrev.00048.2003 · Cited by 817 · see citing works

Glucose Challenge Stimulates Reactive Oxygen Species (ROS) Generation by Leucocytes

Mohanty, P., Hamouda, W., Garg, R., Aljada, A., Ghanim, H., & Dandona, P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6854 · Cited by 621 · see citing works

Insulin Stimulates Testosterone Biosynthesis by Human Thecal Cells from Women with Polycystic Ovary Syndrome by Activating Its Own Receptor and Using Inositolglycan Mediators as the Signal Transduction System¹

Nestler, J. E., Jakubowicz, D. J., Falcon de Vargas, A., Brik, C., Quintero, N., & Medina, F. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4886 · Cited by 617 · see citing works

PAI‐1 and atherothrombosis

Vaughan, D. E. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01420.x · Cited by 508 · see citing works

Reactive Oxygen Species-Induced Oxidative Stress in the Development of Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome

González, F., Rote, N. S., Minium, J., & Kirwan, J. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1696 · Cited by 459 · see citing works

Prevalence and Predictors of Coronary Artery Calcification in Women with Polycystic Ovary Syndrome

Christian, R. C., Dumesic, D. A., Behrenbeck, T. R., Oberg, A. L., Sheedy, P. F., & Fitzpatrick, L. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030334 · Cited by 396 · see citing works

Increased C-Reactive Protein Levels in the Polycystic Ovary Syndrome: A Marker of Cardiovascular Disease

Boulman, N., Levy, Y., Leiba, R., Shachar, S. S., Linn, R., Zinder, O., & Blumenfeld, Z. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031096 · Cited by 332 · see citing works

Insulin Resistance and Atherosclerosis

Nigro, J., Osman, N., Dart, A. M., & Little, P. J. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0007 · Cited by 317 · see citing works

Insulin resistance in aging is related to abdominal obesity

Kohrt, W. M., Kirwan, J. P., Staten, M. A., Bourey, R. E., King, D. S., & Holloszy, J. O. (1993) · Diabetes · doi:10.2337/diab.42.2.273 · Cited by 303 · see citing works

Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome

Kirchengast, S. (2001) · Human Reproduction · doi:10.1093/humrep/16.6.1255 · Cited by 291 · see citing works

Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves

Taylor, R. W., Keil, D., Gold, E., Williams, S., & Goulding, A. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.1.44 · Cited by 285 · see citing works

Evidence for an Association between Metabolic Cardiovascular Syndrome and Coronary and Aortic Calcification among Women with Polycystic Ovary Syndrome

Talbott, E. O., Zborowski, J. V., Rager, J. R., Boudreaux, M. Y., Edmundowicz, D., & Guzick, D. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032237 · Cited by 269 · see citing works

Metformin Reduces Serum C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome

Morin-Papunen, L. C., Rautio, K., Ruokonen, A., Hedberg, P. S. M., Puukka, M., & Tapanainen, J. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021688 · Cited by 245 · see citing works

Androgen Exposure Increases Human Monocyte Adhesion to Vascular Endothelium and Endothelial Cell Expression of Vascular Cell Adhesion Molecule-1

McCrohon, J. A., Jessup, W., Handelsman, D. J., & Celermajer, D. S. (1999) · Circulation · doi:10.1161/01.cir.99.17.2317 · Cited by 242 · see citing works

Increased Activation of Nuclear Factor κB Triggers Inflammation and Insulin Resistance in Polycystic Ovary Syndrome

González, F., Rote, N. S., Minium, J., & Kirwan, J. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2327 · Cited by 228 · see citing works

Effects of Androgens on Coronary Artery Atherosclerosis and Atherosclerosis-Related Impairment of Vascular Responsiveness

Adams, M. R., Williams, J. K., & Kaplan, J. R. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.5.562 · Cited by 209 · see citing works

Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome

Yıldırım, B., Sabir, N., & Kaleli̇, B. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00265-6 · Cited by 195 · see citing works

Ethinylestradiol-Drospirenone, Flutamide-Metformin, or Both for Adolescents and Women with Hyperinsulinemic Hyperandrogenism: Opposite Effects on Adipocytokines and Body Adiposity

Ibáñez, L., & de Zegher, F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031281 · Cited by 172 · see citing works

Inflammatory and endothelial markers in women with polycystic ovary syndrome

Diamanti‐Kandarakis, E., Alexandraki, K., Piperi, C., Protogerou, A. D., Katsikis, I., Paterakis, T., Lekakis, J., & Panidis, D. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01712.x · Cited by 168 · see citing works

The importance of insulin resistance in polycystic ovary syndrome

Goodarzi, M. O., & Korenman, S. G. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00734-9 · Cited by 118 · see citing works

Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea

Vgontzas, A. N., Trakada, G., Bixler, E. O., Lin, H.-M., Pejovic, S., Zoumakis, E., Chrousos, G. P., & Legro, R. S. (2006) · Metabolism · doi:10.1016/j.metabol.2006.04.002 · Cited by 114 · see citing works

Increased Circulating Levels of Matrix Metalloproteinase-2 and -9 in Women with the Polycystic Ovary Syndrome

Lewandowski, K. C., Komorowski, J., O’Callaghan, C. J., Tan, B. K., Chen, J., Prelević, G. M., & Randeva, H. S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0648 · Cited by 97 · see citing works

Hyperglycemia Alters Tumor Necrosis Factor-α Release from Mononuclear Cells in Women with Polycystic Ovary Syndrome

González, F., Minium, J., Rote, N. S., & Kirwan, J. P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0694 · Cited by 97 · see citing works

Insulin resistance in aging is related to abdominal obesity

Kohrt, W. M., Kirwan, J. P., Staten, M. A., et al. (1993) · Diabetes · doi:10.2337/diabetes.42.2.273 · Cited by 89 · see citing works

Human aging is associated with altered TNF-α production during hyperglycemia and hyperinsulinemia

Kirwan, J. P., Krishnan, R. K., Weaver, J. A., Aguila, L. F. D., & Evans, W. J. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1137 · Cited by 81 · see citing works

Evaluation of WHO and NDDG Criteria for Impaired Glucose Tolerance: Results From Two National Samples

Modan, M., Harris, M. I., & Halkin, H. (1989) · Diabetes · doi:10.2337/diab.38.12.1630 · Cited by 80 · see citing works

In vitro evidence that hyperglycemia stimulates tumor necrosis factor-α release in obese women with polycystic ovary syndrome

González, F., Rote, N. S., Minium, J., & Kirwan, J. P. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06579 · Cited by 75 · see citing works

Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?

Orio, F., Palomba, S., Cascella, T., Tauchmanovà, L., Nardo, L. G., Biase, S. D., Labella, D., Russo, T., Tolino, A., Zullo, F., et al. (2004) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61634-3 · Cited by 72 · see citing works

17β-Estradiol, progesterone, and testosterone inversely modulate low-density lipoprotein oxidation and cytotoxicity in cultured placental trophoblast and macrophages

Zhu, X., Bonet, B., & Knopp, R. H. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70462-9 · Cited by 69 · see citing works

Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity

Ibáñez, L. (2004) · Human Reproduction · doi:10.1093/humrep/deh329 · Cited by 44 · see citing works

Altered tumor necrosis factor α release from mononuclear cells of obese reproductive-age women during hyperglycemia

González, F., Minium, J., Rote, N. S., & Kirwan, J. P. (2006) · Metabolism · doi:10.1016/j.metabol.2005.08.022 · Cited by 33 · see citing works

Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples

Modan, M., Harris, M. I., & Halkin, H. (1989) · Diabetes · doi:10.2337/diabetes.38.12.1630 · Cited by 27 · see citing works

[Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome].

Hu, W., Qiao, J., Zhao, S., Zhang, X., & Li, M. (2006) · PubMed · Cited by 18 · see citing works

Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis

Escobar-Morreale, H. F., Luque‐Ramírez, M., & González, F. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.11.036 · Cited by 522 · see citing works

Inflammation in Polycystic Ovary Syndrome: Underpinning of insulin resistance and ovarian dysfunction

González, F. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.003 · Cited by 515 · see citing works

A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)

Siddiqui, S., Mateen, S., Ahmad, R., & Moin, S. (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02625-7 · Cited by 385 · see citing works

Is PCOS an inflammatory process?

Duleba, A. J., & Dokras, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.023 · Cited by 327 · see citing works

Roles of oxidative stress in polycystic ovary syndrome and cancers

Zuo, T., Zhu, M., & Xu, W. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8589318 · Cited by 319 · see citing works

The role of low-grade inflammation in the polycystic ovary syndrome

Repaci, A., Gambineri, A., & Pasquali, R. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.08.002 · Cited by 300 · see citing works

Polycystic ovary syndrome current status and future perspective

Naz, R. K. (2014) · Frontiers in Bioscience-Elite · doi:10.2741/e695 · Cited by 267 · see citing works

Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study

Rençber, S. F., Özbek, S. K., Eraldemir, F. C., Sezer, Z., Kum, T., Ceylan, S., & Güzel, E. (2018) · Journal of Ovarian Research · doi:10.1186/s13048-018-0427-7 · Cited by 233 · see citing works

Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome

Toulis, K. A., Goulis, D. G., Mintziori, G., Kintiraki, E., Eukarpidis, E., Mouratoglou, S., Pavlaki, A., Stergianos, S., Poulasouchidou, M., Tzellos, T., et al. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr025 · Cited by 229 · see citing works

The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer

Savant, S. S., Sriramkumar, S., & O’Hagan, H. M. (2018) · Cancers · doi:10.3390/cancers10080251 · Cited by 211 · see citing works

Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease

Baranova, A. V., Tran, T., Birerdinc, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04579.x · Cited by 146 · see citing works

Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS)

Fruzzetti, F., Perini, D., Russo, M., Bucci, F., & Gadducci, A. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1236078 · Cited by 135 · see citing works

The effects of old, new and emerging medicines on metabolic aberrations in PCOS

Bargiota, Α., & Diamanti‐Kandarakis, E. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812437355 · Cited by 118 · see citing works

Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS)

Rutkowska, A. Z., & Rachoń, D. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2013.871517 · Cited by 108 · see citing works

Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome

Nehir, A., Baştu, E., Demiral, İ., Bulut, H., Doğan, M., & Buyru, F. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2016.1155208 · Cited by 99 · see citing works

A Lower-Carbohydrate, Higher-Fat Diet Reduces Abdominal and Intermuscular Fat and Increases Insulin Sensitivity in Adults at Risk of Type 2 Diabetes

Gower, B. A., & Goss, A. M. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.195065 · Cited by 98 · see citing works

Oxidative stress and cardiovascular complications in polycystic ovarian syndrome

Hyderali, B. N., & Mala, K. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.05.005 · Cited by 96 · see citing works

Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women

Creatsa, M. G., Armeni, E., Stamatelopoulos, K. S., Rizos, D., Georgiopoulos, G. A., Kazani, M. V., Alexandrou, A. P., Dendrinos, S., Augoulea, A., Papamichael, C. M., et al. (2011) · Metabolism · doi:10.1016/j.metabol.2011.06.005 · Cited by 93 · see citing works

The physiological basis of complementary and alternative medicines for polycystic ovary syndrome

Raja-Khan, N. T., Stener‐Victorin, E., Wu, X., & Legro, R. S. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00667.2010 · Cited by 88 · see citing works

Polycystic Ovary Syndrome and Endocrine Disruptors (Bisphenols, Parabens, and Triclosan)—A Systematic Review

Srnovršnik, T., Virant‐Klun, I., & Pinter, B. (2023) · Life · doi:10.3390/life13010138 · Cited by 84 · see citing works

Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell Line

Holmes, S., Singh, M., Su, C., & Cunningham, R. L. (2016) · Endocrinology · doi:10.1210/en.2015-1738 · Cited by 73 · see citing works

Therapeutic Effects of Silibinin Against Polycystic Ovary Syndrome Induced by Letrozole in Rats via Its Potential Anti-Inflammatory and Anti-Oxidant Activities

Marouf, B. H., Dana, O. I., Hassan, A. H., & Ali, O. J. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s379725 · Cited by 71 · see citing works

Identification and treatment of metabolic complications in pediatric obesity

Ode, K. L., Frohnert, B. I., & Nathan, B. M. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-009-9115-7 · Cited by 63 · see citing works

The probiotic supplementation reduced inflammation in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial

Ghanei, N., Rezaei, N., Amiri, G. A., Zayeri, F., Makki, G., & Nasseri, E. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2017.12.047 · Cited by 62 · see citing works

Role of oxidative stress and low-grade inflammation in letrozole-induced polycystic ovary syndrome in the rat

Pandey, V., Singh, A., Singh, A. K., Krishna, A., Pandey, U., & Tripathi, Y. B. (2016) · Reproductive Biology · doi:10.1016/j.repbio.2015.12.005 · Cited by 60 · see citing works

Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome

Hu, W., Qiao, J., Yan, Y., Wang, L., & Li, R. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.03.015 · Cited by 56 · see citing works

Serum paraoxonase 1 activity and oxidant/antioxidant status in Saudi women with polycystic ovary syndrome

Mohamadin, A. M., Habib, F., & Elahi, T. F. (2009) · Pathophysiology · doi:10.1016/j.pathophys.2009.11.004 · Cited by 54 · see citing works

Serum tumor necrosis factor-α, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, pcos, or unexplained infertility

Younis, A. I., Hawkins, K. C., Mahini, H., Butler, W. J., & Garelnabi, M. (2014) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-014-0237-9 · Cited by 53 · see citing works

No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls

Lindholm, A., Blomquist, C. H., Bixo, M., Dahlbom, I., Hansson, T., Poromaa, I. S., & Burén, J. (2011) · Human Reproduction · doi:10.1093/humrep/der096 · Cited by 51 · see citing works

Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome

Gomes, V. A., Vieira, C. S., Jacob‐Ferreira, A. L., Belo, V. D. A., Soares, G. M., Fernandes, J. B. F., Ferriani, R. A., & Tanus-Santos, J. E. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0793-6 · Cited by 51 · see citing works

Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome

González, F., Sia, C. L., Stanczyk, F. Z., Blair, H. E., & Krupa, M. E. (2012) · Endocrine · doi:10.1007/s12020-012-9728-6 · Cited by 48 · see citing works

Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-α levels in non-obese women with polycystic ovary syndrome

Choi, Y. S., Yang, H. I., Cho, S., Jung, J. A., Jeon, Y. E., Kim, H. Y., Seo, S. K., & Lee, B. S. (2012) · Steroids · doi:10.1016/j.steroids.2012.08.005 · Cited by 46 · see citing works

Association between Biomarkers of Low-grade Inflammation and Sex Hormones in Women with Polycystic Ovary Syndrome

Hatziagelaki, E. E., Pergialiotis, V., Kannenberg, J. M., Trakakis, E., Tsiavou, A., Markgraf, D. F., Carstensen‐Kirberg, M., Pacini, G., Roden, M., Dimitriadis, G., et al. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0992-9114 · Cited by 46 · see citing works

Polycystic Ovary Syndrome and Hyperandrogenic States

Chang, R. J., & Dumesic, D. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00021-4 · Cited by 41 · see citing works

The effects of 6-Gingerol on reproductive improvement, liver functioning and Cyclooxygenase-2 gene expression in estradiol valerate – Induced polycystic ovary syndrome in Wistar rats

Pournaderi, P. S., Yaghmaei, P., Khodaei, H., Noormohammadi, Z., & Hejazi, S. H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.057 · Cited by 41 · see citing works

Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena

Rondanelli, M., Perna, S., Faliva, M. A., Monteferrario, F., Repaci, E., & Allieri, F. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3433-z · Cited by 39 · see citing works

Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome

Essah, P. A., Arrowood, J. A., Cheang, K. I., Adawadkar, S., Stovall, D. W., & Nestler, J. E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.05.091 · Cited by 37 · see citing works

Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials

Fadlalmola, H. A., Elhusein, A. M., Al‐Sayaghi, K. M., Albadrani, M. S., Swamy, D. S. V., Mamanao, D. M., El-Amin, E. I., Ibrahim, S. E., & Abbas, S. M. (2023) · Pan African Medical Journal · doi:10.11604/pamj.2023.44.134.32404 · Cited by 36 · see citing works

Cardiometabolic biomarkers in women with polycystic ovary syndrome

van der Ham, K., Louwers, Y. V., & Laven, J. S. E. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.008 · Cited by 39 · see citing works

Role of adipokines in the ovarian function: Oogenesis and steroidogenesis

Nikanfar, S., Oghbaei, H., Rezaei, Y. R., Zarezadeh, R., Jafari-Gharabaghlou, D., Nejabati, H. R., Bahrami, Z., Bleisinger, N., Samadi, N., Fattahi, A., et al. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105852 · Cited by 32 · see citing works

Association between inflammatory biomarker serum procalcitonin and obesity in women with polycystic ovary syndrome

Rashad, N. M., El‐Shal, A. S., & Abdelaziz, A. M. (2012) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2012.10.007 · Cited by 32 · see citing works

Serum Soluble Glycoprotein 130 Concentration Is Inversely Related to Insulin Sensitivity in Women With Polycystic Ovary Syndrome

Nikołajuk, A., Kowalska, I., Karczewska‐Kupczewska, M., Adamska, A., Otziomek, E., Wołczyński, S., Kinalska, I., Górska, M., & Strączkowski, M. (2010) · Diabetes · doi:10.2337/db09-1316 · Cited by 31 · see citing works

The Effect on Inflammation of Adherence to the Mediterranean Diet in Polycystic Ovary Syndrome

Dazıroğlu, M. E. Ç., & Tek, N. A. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00451-6 · Cited by 31 · see citing works

Serum Heat Shock Protein 70 Concentration in Relation to Polycystic Ovary Syndrome in a Non-Obese Chinese Population

Gao, H. Y., Meng, J., Xu, M., Zhang, S., Bishwajit, G., Liu, J., Yao, P., Yan, H., Wang, D., & Liu, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067727 · Cited by 31 · see citing works

Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome

González, F., Kirwan, J. P., Rote, N. S., & Minium, J. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00491.2012 · Cited by 30 · see citing works

Association of circulating monocyte chemoattractant protein‐1 levels with polycystic ovary syndrome: A meta‐analysis

Wu, Z., Fang, L., Li, Y., Yan, Y., Thakur, A., Cheng, J., & Sun, Y. (2021) · American Journal of Reproductive Immunology · doi:10.1111/aji.13407 · Cited by 29 · see citing works

High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome

Aydoğdu, A., Taşçı, İ., Tapan, S., Başaran, Y., Aydoğan, Ü., Meriç, C., Sönmez, A., Aydogdu, S., Akbulut, H., Taşlıpınar, A., et al. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.652719 · Cited by 27 · see citing works

Is there a role for diet in ameliorating the reproductive sequelae associated with chronic low-grade inflammation in polycystic ovary syndrome and obesity?

Riley, J. K., & Jungheim, E. S. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.07.1069 · Cited by 27 · see citing works

Interleukin-6 levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome

Küçük, M., Altınkaya, S. Ö., Nergiz, S., Sezer, S. D., Yüksel, H., Bağlı, İ., & Yıldız, G. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.895981 · Cited by 26 · see citing works

Insights on the NF-κB system in polycystic ovary syndrome, attractive therapeutic targets

Tan, W., Zhang, J., Dai, F., Yang, D., Gu, R., Tang, L., Liu, H., & Cheng, Y. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04736-w · Cited by 25 · see citing works

Relationship between IL-17 and ambulatory blood pressure inpolycystic ovary syndrome

Foroozanfard, F., Soleimani, A., Arbab, E., Samimi, M., & Tamadon, M. R. (2016) · Journal of Nephropathology · doi:10.15171/jnp.2017.04 · Cited by 24 · see citing works

Mindfulness-based stress reduction for overweight/obese women with and without polycystic ovary syndrome: Design and methods of a pilot randomized controlled trial

Raja-Khan, N. T., Agito, K., Shah, J., Stetter, C., Gustafson, T. S., Socolow, H., Kunselman, A. R., Reibel, D. K., & Legro, R. S. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.01.021 · Cited by 24 · see citing works

Treatment with d -chiro-inositol and alpha lipoic acid in the management of polycystic ovary syndrome

Fruzzetti, F., Capozzi, A., Canu, A., & Lello, S. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1540573 · Cited by 23 · see citing works

Beneficial effects of pioglitazone and metformin in murine model of polycystic ovaries via improvement of chemerin gene up-regulation

Kabiri, N., Tabandeh, M. R., & Tabatabaie, S. R. F. (2014) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-22-39 · Cited by 22 · see citing works

Review of the effects of polycystic ovary syndrome on Cognition: Looking beyond the androgen hypothesis

Perović, M., Wugalter, K. A., & Einstein, G. (2022) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2022.101038 · Cited by 21 · see citing works

Expression of the CD11c gene in subcutaneous adipose tissue is associated with cytokine level and insulin resistance in women with polycystic ovary syndrome

Tao, T., Li, S., Zhao, A., Zhang, Y., & Liu, W. Y. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0340 · Cited by 21 · see citing works

Elevated Circulating Levels of Tissue Factor in Polycystic Ovary Syndrome

González, F., Kirwan, J. P., Rote, N. S., & Minium, J. (2012) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612436673 · Cited by 21 · see citing works

Hemostatic and Fibrinolytic Abnormalities in Polycystic Ovary Syndrome

Zoppini, G., Bonora, E., Moghetti, P., & Targher, G. (2014) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0034-1384512 · Cited by 21 · see citing works

Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome

Morrison, S. A., Goss, A. M., Azziz, R., Raju, D. A., & Gower, B. A. (2016) · Human Reproduction · doi:10.1093/humrep/dew279 · Cited by 20 · see citing works

Acrylonitrile exposure triggers ovarian inflammation and decreases oocyte quality probably via mitochondrial dysfunction induced apoptosis in mice

Luo, Y.-S., He, Q., Sun, M.-X., Qiao, F.-X., Liu, Y., Xu, C.-L., Xu, Z., Zhao, S.-C., Wang, H., Qi, Z., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109934 · Cited by 20 · see citing works

Identification of key biomarkers for predicting atherosclerosis progression in polycystic ovary syndrome via bioinformatics analysis and machine learning

Zhang, W., Wu, Y., Yuan, Y., Wang, L., Yu, B., Li, X., Yao, Z., & Liang, B. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.109239 · Cited by 20 · see citing works

Increased monocyte chemoattractant protein-1 levels indicating early vascular damage in lean young PCOS patients

Atabekoğlu, C. S., Sönmezer, M., Özmen, B., Gürsoy, A. Y., Akbıyık, F., Taşçı, T., & Aytaç, R. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.08.030 · Cited by 20 · see citing works

04 / Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: An experimental study

Rençber, S. F. (2018) · doi:10.26226/morressier.5af300b3738ab10027aa9a24 · Cited by 21 · see citing works

Alpha Lipoic Acid Efficacy in PCOS Treatment: What Is the Truth?

Guarano, A., Capozzi, A., Cristodoro, M., Simone, N. D., & Lello, S. (2023) · Nutrients · doi:10.3390/nu15143209 · Cited by 19 · see citing works

Decreased Adiponectin Levels in Polycystic Ovary Syndrome, Independent of Body Mass Index

Sharifi, F., Hajihosseini, R., Mazloomi, S., Amirmogaddami, H., & Nazem, H. (2009) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0036 · Cited by 19 · see citing works

Saturated fat ingestion stimulates proatherogenic inflammation in polycystic ovary syndrome

González, F., Considine, R. V., Abdelhadi, O. A., Xue, J., & Acton, A. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00213.2021 · Cited by 18 · see citing works

Hepatic steatosis in overweight/obese females: Newscreening method for those at risk

Tarantino, G., Pizza, G., Colao, A., Pasanisi, F., Conca, P., Colicchio, P., Finelli, C., Contaldo, F., Somma, C. D., & Savastano, S. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5693 · Cited by 18 · see citing works

Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome

Koiou, E., Τζιόμαλος, Κ., Dinas, K. D., Katsikis, I., Kandaraki, E., Tsourdi, E. A., Mavridis, S., & Panidis, D. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0023 · Cited by 18 · see citing works

Association between serum levels and pentanucleotide polymorphism in the sex hormone binding globulin gene and cardiovascular risk factors in females with polycystic ovary syndrome

BALDANI, D. P., SKRGATIC, L., CERNE, J. Z., OGUIC, S. K., GERSAK, B. M., & GERSAK, K. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2014.3117 · Cited by 18 · see citing works

Adipose-androgen crosstalk in polycystic ovary syndrome: mechanisms and therapeutic implications

Ni, M., Lei, H., Ye, T., & Wang, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1731179 · Cited by 22 · see citing works

Polycystic Ovary Syndrome: Focus on Platelets and Prothrombotic Risk

Dasanu, C. A., Clark, B. A., Ichim, T. E., & Alexandrescu, D. T. (2011) · Southern Medical Journal · doi:10.1097/smj.0b013e31820c0172 · Cited by 17 · see citing works

Soluble platelet/endothelial cell adhesion molecule (sPECAM)-1 is increased in polycystic ovary syndrome and related to endothelial dysfunction

Pepene, C. E. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.632792 · Cited by 17 · see citing works

Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-α Levels in Women with Polycystic Ovary Syndrome: A Pilot Study

Yousuf, S. D., Rashid, F., Mattoo, T., Shekhar, C., Mudassar, S., Zargar, M. A., & Ganie, M. A. (2016) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2016.06.010 · Cited by 16 · see citing works

PAI‐1 in granulosa cells is suppressed directly by statin and indirectly by suppressing TGF‐β and TNF‐α in mononuclear cells by insulin‐sensitizing drugs

Yamada‐Nomoto, K., Yoshino, O., Akiyama, I., Iwase, A., Ono, Y., Nakamura, T., Harada, M., Nakashima, A., Shima, T., Ushijima, A., et al. (2017) · American Journal of Reproductive Immunology · doi:10.1111/aji.12669 · Cited by 16 · see citing works

Diagnostic and prognostic biomarkers in Polycystic Ovary Syndrome

Singh, I., Moar, K., & Maurya, P. K. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120425 · Cited by 15 · see citing works

Arterial stiffness measured by cardio‐ankle vascular index is greater in non‐obese young women with polycystic ovarian syndrome

Kılıç, D., Kılıç, İ. D., Sevgican, C. İ., Kilic, O., Alataş, E., Arslan, M., Avcı, E., & Güler, T. (2020) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14543 · Cited by 15 · see citing works

Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome

Moradi, S., Mollabashi, M., & Kerman, S. R. J. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.501876 · Cited by 15 · see citing works

Ibuprofen Reduces Testosterone Level in Women With Polycystic Ovary Syndrome

Banaszewska, B., Ożegowska, K., Polska, M., Pawelczyk, L. A., Chang, R. J., & Dulęba, A. J. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac128 · Cited by 14 · see citing works

Association of Mean Platelet Volume With Androgens and Insulin Resistance in Nonobese Patients With Polycystic Ovary Syndrome

Dogan, B. A., Arduç, A., Tuna, M. M., Karakılıç, E., Duran, İ. D., Tütüncü, Y., Berker, D. S., & Güler, S. (2014) · Intern J Endocrinol Metab · doi:10.5812/ijem.18642 · Cited by 14 · see citing works

Is the polycystic ovary syndrome the causative of the increase in inflammatory markers and metabolic risk?

Rey-Roldán, E. B., Lana, M. B. P., Galluzzo, L., Blanco, G., Onetto, C., Straminsky, V., & Nolting, M. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.730581 · Cited by 14 · see citing works

Fat Distribution and its Correlation with Insulin Resistance, Androgen Markers, and Proinflammatory Cytokines in Polycystic Ovary Syndrome

Cavalcante, R. B. D. M., Leão, L. M. C. S. M., Tavares, A. B. W., Lopes, K. G., & Kraemer‐Aguiar, L. G. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2386-9281 · Cited by 13 · see citing works

Genetic Variation in the Mcp-1 Gene Promoter Associated with the Risk of Polycystic Ovary Syndrome

Li, L., Ryoo, J. E., Lee, K.-J., Choi, B. C., & Baek, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123045 · Cited by 13 · see citing works

Impact of interlukin-6 on central obesity measures in women with polycystic ovarian syndrome

Alissa, E. M., Algarni, S. A., Khaffji, A. J., & Mansouri, N. M. A. (2020) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2019.1697219 · Cited by 13 · see citing works

Increased serum C-reactive protein levels in normal weight women with polycystic ovary syndrome.

Makedos, A., Goulis, D. G., Arvanitidou, M., Mintziori, G., Papanikolaou, A., Makedou, A., & Panidis, D. (2011) · PubMed Central · Cited by 13 · see citing works

Serum High-Sensitivity C-Reactive Protein and Homocysteine Changes During Hormonal Therapy in Women With Polycystic Ovary Syndrome: A Prospective, Matched Study

Makedos, A., Goulis, D. G., Papanikolaou, A., & Panidis, D. (2010) · Angiology · doi:10.1177/0003319709361198 · Cited by 13 · see citing works

The polycystic ovary syndrome (pcos) status and cardiovascular risk in young women

Ilie, I. R. P., Pepene, C. E., Marian, I., Mocan, T., Hazi, G. M., Dragotoiu, G., Ilie, R., MOCAN, L. C., & Duncea, I. (2010) · Open Medicine · doi:10.2478/s11536-010-0054-1 · Cited by 11 · see citing works

Evidence of mononuclear cell preactivation in the fasting state in polycystic ovary syndrome

González, F., Kirwan, J. P., Rote, N. S., & Minium, J. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.06.044 · Cited by 10 · see citing works

On the Intimate Relationship of Adiposity to Polycystic Ovary Syndrome

Rosenfield, R. L., & Dumesic, D. A. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf527 · Cited by 9 · see citing works

Polycystic ovary syndrome and related inflammation in radiomics; relationship with patient outcome

Zheng, C.-Y., Yu, Y., & Bai, X. (2023) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2023.02.013 · Cited by 9 · see citing works

Effect of colchicine on polycystic ovary syndrome: an experimental study

Gözükara, İ., Pınar, N., Özcan, O., Özgür, T., Dokuyucu, R., Kurt, R. K., Kucur, S. K., & Aksoy, A. N. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3933-5 · Cited by 9 · see citing works

Effects of Insulin Resistance on Myocardial Blood Flow and Arterial Peripheral Circulation in Patients with Polycystic Ovary Syndrome

Aldrighi, J. M., Tsutsui, J. M., Kowastch, I., Ribeiro, A. L., Scapinelli, A., Tamanaha, S., de Oliveira, R. M., & Mathias, W. (2014) · Echocardiography · doi:10.1111/echo.12849 · Cited by 9 · see citing works

Prenatal Testosterone Exposure Induces Insulin Resistance, Uterine Oxidative Stress and pro-Inflammatory Status in Rats

Ferreira, S. R., Goyeneche, A. A., Heber, M. F., Abruzzese, G. A., Ferrer, M. J., Telleria, C. M., & Motta, A. B. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111045 · Cited by 8 · see citing works

Polycystic ovary syndrome and immune deregulation: what do hormones want to say?

Johnson, B. S., & Laloraya, M. (2022) · Exploration of Immunology · doi:10.37349/ei.2022.00058 · Cited by 8 · see citing works

Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome

Lam, U. D. P., Lerchbaum, E., Schweighofer, N., Trummer, O., Eberhard, K., Genser, B., Pieber, T. R., & Obermayer-Pietsch, B. M. (2014) · Gene · doi:10.1016/j.gene.2013.12.055 · Cited by 8 · see citing works

Serum lipoprotein(a) and lipid profile in polycystic ovarian syndrome

Ravi, B. V., Swetha, R., & Nalini, K. (2015) · The Journal of Clinical and Scientific Research · doi:10.15380/2277-5706.jcsr.14.007 · Cited by 8 · see citing works

Paraoxonase single nucleotide variants show associations with polycystic ovary syndrome: a meta-analysis

Kunjantarachot, A., Pabalan, N., Jarjanazi, H., Christofolini, D. M., Montagna, E., Barbosa, C. P., & Bianco, B. A. V. (2020) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00665-1 · Cited by 7 · see citing works

The effects of testosterone on transgender males on carotid intima-media thickness and serum inflammatory markers compared within patients with polycystic ovary syndrome

Balık, A. Ö., Vural, F., Alpoğan, O., Özoğul, M., & Dönmez, E. E. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2112942 · Cited by 7 · see citing works

The ICAM-1 Gly241Arg Polymorphism is Not Associated With Polycystic Ovary Syndrome - Results from a Case Control study in Kashmir, India

Yousuf, S. D., Ganie, M. A., Zargar, M. A., Parvez, T., & Rashid, F. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2016.17.3.1583 · Cited by 7 · see citing works

High prevalence of benign mammary tumors in a rat model of polycystic ovary syndrome during postmenopausal period

Noroozzadeh, M., Behboudi‐Gandevani, S., Mosaffa, N., Tohidi, M., & Tehrani, F. R. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1576613 · Cited by 8 · see citing works

Obesity, Metabolic Dysfunction, and Inflammation in Polycystic Ovary Syndrome

Aubuchon, M., Bickhaus, J. A., & González, F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_8 · Cited by 7 · see citing works

Glucose and lipopolysaccharide regulate proatherogenic cytokine release from mononuclear cells in polycystic ovary syndrome

González, F., Kirwan, J. P., Rote, N. S., Minium, J., & O’Leary, V. B. (2014) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2014.01.001 · Cited by 12 · see citing works

Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome

González, F., Kirwan, J. P., Rote, N. S., & Minium, J. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00491.2012 · Cited by 30 · see citing works

Elevated Circulating Levels of Macrophage Migration Inhibitory Factor in Polycystic Ovary Syndrome

González, F., Rote, N. S., Minium, J., Weaver, A. L., & Kirwan, J. P. (2010) · Cytokine · doi:10.1016/j.cyto.2010.06.008 · Cited by 35 · see citing works

Mean values of hormones involved in male reproduction at different ages

Sorcini, G., Genderini, M., Felicetti, C., Fabietti, E., Matarazzo, G., & Marini, S. (1981) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(81)90092-3

Steroid levels in the short-term response to hCG in normal, impotent and oligozoospermic men

Krause, W. K. H., & Wichmann, U. (1981) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(81)90093-5